Cited by 1,076COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19

The DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.

Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients

Open access

Xiong, Yong, Liu, Yuan, Cao, Liu, Wang, Dehe, Guo, Ming, Jiang, Ao, Guo, Dong, Hu, Wenjia, Yang, Jiayi, Tang, Zhidong, Wu, Honglong, Lin, Yongquan, Zhang, Meiyuan, Zhang, Qi, Shi, Mang, Liu, Yingle, Zhou, Yu, Lan, Ke, Chen, Yu·2020·Emerging Microbes & Infections

DOI 10.1080/22221751.2020.1747363PMC PMC7170362

Open this paper in CoChat — free account

Abstract

Circulating in China and 158 other countries and areas, the ongoing COVID-19 outbreak has caused devastating mortality and posed a great threat to public health. However, efforts to identify effectively supportive therapeutic drugs and treatments has been hampered by our limited understanding of host immune response for this fatal disease. To characterize the transcriptional signatures of host inflammatory response to SARS-CoV-2 (HCoV-19) infection, we carried out transcriptome sequencing of the RNAs isolated from the bronchoalveolar lavage fluid (BALF) and peripheral blood mononuclear cells (PBMC) specimens of COVID-19 patients. Our results reveal distinct host inflammatory cytokine profiles to SARS-CoV-2 infection in patients, and highlight the association between COVID-19 pathogenesis and excessive cytokine release such as CCL2/MCP-1, CXCL10/IP-10, CCL3/MIP-1A, and CCL4/MIP1B. Furthermore, SARS-CoV-2 induced activation of apoptosis and P53 signalling pathway in lymphocytes may be the cause of patients' lymphopenia. The transcriptome dataset of COVID-19 patients would be a valuable resource for clinical guidance on anti-inflammatory medication and understanding the molecular mechansims of host response.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1080/22221751.2020.1747363

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Figure 1. Genome-wide profiling of gene expression in BALF and PBMC of COVID-19 patients. (A) Experimental design. PBMC and BALF were prepared from patients or control. Total RNA was extracted and analysed by RNA-seq to identify differentially expressed genes implicated in COVID-19 disease pathogenesis. (B, C) Heat map of genes significantly up-regulated and down-regulated (fold change > 2) in COVID-19 patients BALF (B, WHU01-2 vs. Ctrl1-3) and PBMC (C, P1-3 vs. N1-3) compared to controls, respectively. (D-F) RNA-seq signals in PBMC patients (P1, P2, P3) and healthy controls (N1, N2, N3) for 3 genes: IL6 (D), IL6R (E), and TP53 (F), respectively. The scale on the y axis indicates the read density per million of total normalized reads.CC BY · PubMed Central

Figure 2. GO-term and KEGG pathway enrichment of up-regulated expressed genes in BALF and PBMC of COVID-19 patients. (A) GO-term functional enrichment by 3 categories (BP, MF, CC) and KEGG pathway analysis were performed for up-regulated genes in COVID-19 patients BALF. (B) Same as (A) for up-regulated genes in COVID-19 patients PBMC.CC BY · PubMed Central

Figure 3. GO-term and KEGG pathway enrichment of down-regulated expressed genes in BALF and PBMC of COVID-19 patients. (A) GO-term functional enrichment by 3 categories (BP, MF, CC) and KEGG pathway analysis were performed for down-regulated genes in COVID-19 patients BALF. (B) Same as (A) for down-regulated genes in COVID-19 patients PBMC.CC BY · PubMed Central

Figure 4. Inflammatory cytokines expression in COVID-19 patients. Heat map depicting inflammatory cytokine genes expression in COVID-19 patients BALF (A, WHU01-02 vs. Ctrl1-3) and PBMC (B, P1-3 vs. N1-3) compared with control. Genes significantly up-regulated and down-regulated are labelled with asterisks.CC BY · PubMed Central

Figure 5. Apoptosis-related pathway in PBMC. The heatmaps show the expression levels of differentially expressed genes in different signaling pathways, including (A) autophagy (- animal species) signal pathway, (B) apoptosis signal pathway, (C) p53 signaling pathway. Genes significantly up-regulated and down-regulated are labelled with asterisks.CC BY · PubMed Central

Figure 6. Comparison of differentially expressed genes in BALF and PBMC. (A) Venn diagram showing the number of changed genes with same or different trends between BALF and PBMC samples. (B) Heat map depicting the scaled gene expression changes with same or different trends between BALF and PBMC samples.CC BY · PubMed Central

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Yu, G., Wang, L.-G., Han, Y., & He, Q.-Y. (2012) · OMICS: A Journal of Integrative Biology · doi:10.1089/omi.2011.0118 · Cited by 36,259
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Self-citation
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Liao, Y., Smyth, G. K., & Shi, W. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt656 · Cited by 27,219
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Epidemiological and clinical characteristics of 99 cases of 2019 novel Coronavirus pneumonia in Wuhan, China: a descriptive study.
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Self-citation
Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-Infected pneumonia in Wuhan, China
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
Self-citation
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463

Show all 53 references

Sorted by citations

Items 801–900 of 1,000

A Nomogram for Predicting Delayed Viral Shedding in Non-Severe SARS-CoV-2 Omicron Infection
Yu, T., Dong, J., Qi, Q., Lv, Q., Li, ., Huang, C., & Cai, X. (2023) · Infection and Drug Resistance · doi:10.2147/idr.s407620 · Cited by 4
Blood coagulation, risk factors and associated complications in COVID-19 patients in Saudi Arabia: A retrospective cohort study
AlNafea, H. M., Al-Qahtani, M. T., Gahtani, F. H. A., & Tabassum, H. (2023) · Medicine · doi:10.1097/md.0000000000035621 · Cited by 4
Bioinformatics and system biology analysis revealed the crosstalk between COVID‐19 and osteoarthritis
Lai, B.-W., Jiang, H., Liao, T., Gao, Y., & Zhou, X. (2023) · Immunity Inflammation and Disease · doi:10.1002/iid3.1123 · Cited by 4
Hot Topic Commentary on COVID-19
Kong, A. T., Lau, A. T. Y., & Brunetti, L. (2020) · Current Pharmacology Reports · doi:10.1007/s40495-020-00215-8 · Cited by 4
Targeting thromboinflammation in COVID-19 – A narrative review of the potential of C1 inhibitor to prevent disease progression
Urwyler, P., Moser, S., Trendelenburg, M., Sendi, P., & Osthoff, M. F. (2022) · Molecular Immunology · doi:10.1016/j.molimm.2022.08.008 · Cited by 4
The effectiveness of coagulation parameters in classifying patients and predicting mortality in Covid-19
Şener, G. (2022) · Journal of Experimental and Clinical Medicine · doi:10.52142/omujecm.39.1.45 · Cited by 4
Ultradiluted SARS-CoV-2 Spike Protein mitigates hyperinflammation in lung via ferritin and MMP-9 regulation in BALB/c mice
Roy, A., Sarkar, A., Nayak, D., & Das, S. (2023) · Virus Research · doi:10.1016/j.virusres.2023.199091 · Cited by 4
Immunotherapy during COVID-19 pandemic: An experience at a tertiary care center in India
Pathak, A., Gupta, A., Rathore, A., Sud, R., Swamy, S. S., Pandaya, T., Dubey, A., & Guleria, B. (2021) · Clinical Cancer Investigation Journal · doi:10.51847/sis8apuekuo882 · Cited by 4
Integrated multi-omics approach identified molecular mechanism and pathogenetic processes of COVID-19 that affect patient with Parkinson’s disorder
Zhao, H., Zhang, Q., Chen, H., Rahman, M. R., & Faruquee, H. M. (2021) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2021.07.074 · Cited by 4
Self-citation
Identification of Repurposal Drugs and Adverse Drug Reactions for Various Courses of Coronavirus Disease 2019 (COVID-19) Based on Single-cell RNA Sequencing DataPreprint
Guo, K., Wang, Z., Gao, P., Pu, Q., Wu, M., Huang, C., & Hur, J. (2020) · arXiv (Cornell University) · Cited by 4
Meta-analysis of virus-induced host gene expression reveals unique signatures of immune dysregulation induced by SARS-CoV-2Preprint
Srikeerthana, K., Gu, Q., Palmarini, M., Wilson, S. J., & Robertson, D. L. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.29.424739 · Cited by 3
SARS-CoV-2 infection of circulating immune cells is not responsible for virus dissemination in severe COVID-19 patientsPreprint
Rosin, N. L., Jaffer, A., Sinha, S., Mulloy, R. P., Robinson, C. A., Labit, E., de Almeida, L. G. N., Dufour, A., Corcoran, J. A., Yipp, B. G., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.19.427282 · Cited by 4
scPanel: a tool for automatic identification of sparse gene panels for generalizable patient classification using scRNA-seq datasets
Xie, Y., Yang, J., Ouyang, J. F., & Petretto, E. G. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae482 · Cited by 5
Self-citation
Age-related immune response disparities between adults and children with severe COVID-19: a case–control study in China
Chen, H., Li, Y., Yuan, L., Liu, F., Sun, Q., Luo, Q., Lei, Y., Hou, Y., Li, J., Cai, L., et al. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1525051 · Cited by 3
Cathepsin S contributes to influenza-induced lung injury by driving inflammation, promoting apoptosis, and disrupting epithelial barrier integrity
Ma, T., Yang, C., Wang, Y., Tu, C., Zhang, J., Mai, K., Wu, S., Zhou, H., Li, S., Ye, S., et al. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.01128-25 · Cited by 3
The association of oxygen saturation, tomography findings and d-dimer levels in coronavirus disease 2019 patients
Yalçın, K. S., Kasapoğlu, B., ALANLI, R., KÜÇÜKAY, M. B., & KOŞAR, A. (2020) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0000000000000964 · Cited by 3
Network-based analysis between SARS-CoV-2 receptor ACE2 and common host factors in COVID-19 and asthma: Potential mechanistic insights
Yan, Q., Xue-ying, L., Peng, C.-W., Zheng, W., Liu, X., Wen, W., Jiang, Y., Zhan, S., & Huang, X. (2023) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2023.105502 · Cited by 4
Comparative analysis of MxA, OAS1, PKR gene expression levels in leukocytes of patients with influenza and coronavirus infection
Klotchenko, S. A., Romanovskaya-Romanko, E., Oleynik, V. A., Egorova, M. A., Monakhova, V. S., Валерьевич, В. Е., & Plotnikova, M. A. (2023) · Medical academic journal · doi:10.17816/maj623374 · Cited by 4
Efficacy of interleukin-6 inhibitors as a tool for preventive anti-inflammatory therapy for COVID-19
Zyryanov, S. K., Butranova, O. I., & Abramova, A. A. (2024) · Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice · doi:10.37489/2588-0519-2024-1-4-16 · Cited by 3
Comparative Analysis of Lymphocyte Populations in Post-COVID-19 Condition and COVID-19 Convalescent Individuals
Berger, L., Wolf, J., Kalbitz, S., Kellner, N., Lübbert, C., & Borte, S. (2024) · Diagnostics · doi:10.3390/diagnostics14121286 · Cited by 5
Harnessing high-throughput OMICS in emerging zoonotic virus preparedness and response activities
Loeb, K., Lemaille, C., Frederick, C., Wallace, H. L., & Kindrachuk, J. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167337 · Cited by 3
Chronic prostatitis/chronic pelvic pain syndrome impairs erectile function by inducing apoptosis in a rat model of experimental autoimmune prostatitis
Gu, Q., Luan, J., Yu, M., Xia, J., & Wang, Z. (2024) · International Journal of Impotence Research · doi:10.1038/s41443-024-00965-9 · Cited by 3
VirTAXA: enhancing RNA virus taxonomic classification with remote homology search and tree-based validation
Zhu, Y., Chen, G., & Sun, Y. (2024) · Bioinformatics · doi:10.1093/bioinformatics/btae575 · Cited by 3
Maraviroc treatment for hospitalized participants with non-severe COVID-19 at risk of progression: a randomized, proof-of-concept clinical trial
Gasca‐Capote, C., Lomas-Cabezas, J. M., Saborido-Alconchel, A., Moral-Turón, C., Navarro, M. D., Ramos, A., Borrego, M. P., Villalba, A. M., Rivas‐Jeremías, I., Domínguez, M., et al. (2025) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2025.07.007 · Cited by 3
Can the immune system be targeted to treat COVID-19?
Abdelhafeez, S., & Doherty, D. G. (2021) · European Respiratory Society eBooks · doi:10.1183/2312508x.10024120 · Cited by 3
Clinical and immune response characteristics among vaccinated persons infected with SARS-CoV-2 delta variant: a retrospective study
Wang, C., Li, Y., Pan, Y., Zhou, L., Zhang, X., Yan, W., Guo, F., Shu, Y., & Gao, J. (2022) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2200054 · Cited by 3
Natural drugs for the treatment of severe acute respiratory syndrome coronaviruses infections (SARS-CoV and COVID-19)
Bachir, Y. N. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-95578-2.00014-5 · Cited by 3
Transcriptomic approaches in COVID-19: From infection to vaccines
Gardinassi, L. G., Souza, C. O. S., de Lima, D. V., Sales‐Campos, H., & Fonseca, S. G. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91794-0.00003-2 · Cited by 3
Immunometabolic interference between cancer and COVID-19
Consonni, F. M., Durante, B., Manfredi, M., Bleve, A., Pandolfo, C., Garlatti, V., Vanella, V. V., Marengo, E., Barberis, E., Bottazzi, B., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1168455 · Cited by 3
Analysing transcriptomic signatures and identifying potential genes for the protective effect of inactivated COVID-19 vaccines
Chen, H.-Q., Zhang, L., Xu, C., Shen, X.-Y., Lou, J., & Wu, S. (2023) · PeerJ · doi:10.7717/peerj.15155 · Cited by 4
IL-10/IL-6 ratio from nasal & oral swab samples, acts as an inflammatory indicator for COVID-19 patients infected with the delta variant
Biswas, B. K., Roy, S., Banerjee, I., Jana, S., Bhattacharjee, B., Chakraborty, S. K., Mondal, A., & Goswami, R. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e16985 · Cited by 3
ACE2 expression and spike S1 protein‐mediated immune responses in oral mucosal cells
Akagi, M., Ohta, K., Fukada, S., Sakuma, M., Naruse, T., Nakagawa, T., Ono, S., Nishi, H., Shigeishi, H., & Aikawa, T. (2023) · Oral Diseases · doi:10.1111/odi.14670 · Cited by 3
Aminoacyl-tRNA synthetase interactions in SARS-CoV-2 infection
Khan, D., & Fox, P. L. (2023) · Biochemical Society Transactions · doi:10.1042/bst20230527 · Cited by 3
Identification of Leading Compounds from Euphorbia neriifolia (Dudsor) Extracts as a Potential Inhibitor of SARS-CoV-2 ACE2-RBDS1 Receptor Complex: An Insight from Molecular Docking ADMET Profiling and MD-simulation Studies
Pramanik, M. E. A., Miah, M. M. Z., Ahmed, I., Hossain, A. M., Haque, M. J., Islam, A. M., Jahan, R. A., Haque, M. E., Rahman, M. M., Basak, P. M., et al. (2023) · Euroasian Journal of Hepato-Gastroenterology · doi:10.5005/jp-journals-10018-1414 · Cited by 3
Nanomedicine at the Pulmonary Frontier: Immune-Centric Approaches for Respiratory Disease Treatment
Kaur, J. K., Sharma, A., Passi, G., Dey, P., Khajuria, A., Alajangi, H. K., Jaiswal, P. K., Barnwal, R. P., & Singh, G. (2024) · Immunological Investigations · doi:10.1080/08820139.2023.2298398 · Cited by 3
An Evaluation of Type 1 Interferon Related Genes in Male and Female-Matched, SARS-CoV-2 Infected Individuals Early in the COVID-19 Pandemic
Huecksteadt, T., Myers, E., Aamodt, S., Trivedi, S., & Warren, K. (2024) · Viruses · doi:10.3390/v16030472 · Cited by 3
COVID-19: an updated review
Isihak, F. A., Hamad, M. A., & Mustafa, N. G. (2020) · Russian Journal of Infection and Immunity · doi:10.15789/2220-7619-cau-1443 · Cited by 3
Covid-19, Trust, And Vulnerability In North Halmahera District of Indonesia
Singgalen, Y. A. (2021) · ARISTO · doi:10.24269/ars.v9i2.2598 · Cited by 3
A COVID-19 Overview and Potential Applications of Cell Therapy
Câmara, D. A. D., Porcacchia, A. S., Lizier, N. F., & de-Sá-Júnior, P. L. (2021) · Biologics · doi:10.3390/biologics1020011 · Cited by 3
Longitudinal Characterization of Cytokine Overproduction: A Case Report in Critically Ill COVID-19 Patients With Hyperinflammation in Bronchoalveolar Lavage
Luo, Z., Zhu, C., Ruan, Z., Cui, X., Shereen, M. A., Pan, P., Huang, J., Wang, X., Su, H., Xia, Y., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.690523 · Cited by 3
Automated COVID-19 Detection from WBC-DIFF Scattergram Images with Hybrid CNN Model Using Feature Selection
Ayyıldız, H., Kalaycı, M. Z., Tuncer, S. A., Çınar, A., & Tuncer, T. (2022) · Traitement du signal · doi:10.18280/ts.390206 · Cited by 3
Creating bioinformatics matrix of molecular markers to predict risk-associated health disorders
Zemlyanova, M. A., Zaitseva, N. V., Koldibekova, Y. V., Пескова, Е. В., & Bulatova, N. I. (2022) · Health Risk Analysis · doi:10.21668/health.risk/2022.2.16 · Cited by 3
Lymphopenia in the COVID-19 Patient: More than a Predictor of Poor Prognosis?
Rondón-Carvajal, J. (2021) · JOURNAL OF COMMUNICABLE DISEASES · doi:10.24321/0019.5138.202116 · Cited by 2
Human bronchial-pulmonary proteomics in coronavirus disease 2019 (COVID-19) pandemic: applications and implications
Tan, H. W., Xu, Y., & Lau, A. T. Y. (2021) · Expert Review of Proteomics · doi:10.1080/14789450.2021.2010549 · Cited by 3
Antiviral Immunity in SARS-CoV-2 Infection: From Protective to Deleterious Responses
Mihăescu, G., Chifiriuc, M. C., Vrâncianu, C. O., Constantin, M., Filip, R., Popescu, M. R., Burlibaşa, L., Nicoară, A. C., Bolocan, A., Iliescu, C., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9122578 · Cited by 3
The accessible promoter-mediated supplementary effect of host factors provides new insight into the tropism of SARS-CoV-2
Du, G., Xu, X., Wang, J., Wang, X., Ding, Y., Li, F., Sun, Y., Tao, H., Luo, Y., Li, H., et al. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.03.010 · Cited by 3
Reconstructed signaling and regulatory networks identify potential drugs for SARS-CoV-2 infectionPreprint
Ding, J., Lugo-Martinez, J., Yuan, Y., Huang, J., Hume, A. J., Suder, E. L., Mühlberger, E., Kotton, D. N., & Bar‐Joseph, Z. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.01.127589 · Cited by 3
Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19Preprint
Le, B. L., Andreoletti, G., Oskotsky, T., Vallejo-Gracia, A., Rosales, R., Yu, K., Kosti, I., Leon, K. E., Bunis, D. G., Li, C., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-333578/v1 · Cited by 3
COVID-19 mortality prediction model, 3C-M, built for use in resource limited settings - understanding the relevance of neutrophilic leukocytosis in predicting disease severity and mortalityPreprint
Agarwal, N., Dua, D., Sud, R., Yadav, M., Agarwal, A., & Vijayan, V. (2021) · medRxiv · doi:10.1101/2021.08.05.21261565 · Cited by 3
Drug Repurposing for COVID-19 from FDA Approved and Experiment Stage Drugs by in Silico Methods with SARS CoV-2 Spike ProteinPreprint
Sharanya, C. S., Kumar, A., Jayanandan, A., Abdulhameed, S., & Madathilkovilakathu, H. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12324980.v1 · Cited by 3
Longitudinal transcriptional changes reveal genes from the natural killer cell-mediated cytotoxicity pathway as critical players underlying COVID-19 progressionPreprint
Medina, M. A., Fuentes‐Villalobos, F., Quevedo, C., Aguilera, F., Riquelme, R., Rioseco, M. L., Barria, S., Pinos, Y., Calvo, M. A., Burbulis, I. E., et al. (2024) · eLife · doi:10.7554/elife.94242 · Cited by 4
Pathogenesis, Symptomatology, and Transmission of SARS-CoV-2 through Analysis of Viral Genomics and Structure
Rando, H. M., MacLean, A. L., Lee, A. J., Lordan, R., Ray, S., Bansal, V., Skelly, A. N., Sell, E., Dziak, J. J., Shinholster, L., et al. (2021) · mSystems · doi:10.1128/msystems.00095-21 · Cited by 42
Landscape of chimeric RNAs in COVID-19 patient blood
Haddox, S., Wu, P., Singh, S., Qin, F., Engel, J. A., Kian, A., Ahmad, S., Li, H., & Wu, P. (2024) · Genes & Diseases · doi:10.1016/j.gendis.2024.101348 · Cited by 2
Insights into dysregulated innate immunity in the pathogenesis of COVID-19-associated pulmonary aspergillosis
Xiang, H., Zhang, L., Cai, M., & Zhang, Y. (2025) · Infection · doi:10.1007/s15010-025-02495-y · Cited by 2
An RGD motif on SARS-CoV-2 Spike induces TGF-β signaling and downregulates interferon
Gracie, N. P., Aggarwal, A., Luo, R., Spicer, M., Idrees, S., Ashley, C. L., Alca, S., Ison, T., Steain, M. C., Patel, K., et al. (2025) · Journal of Virology · doi:10.1128/jvi.00435-25 · Cited by 2
Potential immunomodulatory role of sesamin in combating immune dysregulation associated with COVID-19
Majdalawieh, A. F., Yousef, S. M., & Abu‐Yousef, I. A. (2021) · Asian Pacific Journal of Tropical Biomedicine · doi:10.4103/2221-1691.326096 · Cited by 2
Pulmonary fibrosis associated with COVID-19
Кузубова, Н. А., Titova, O. N., Lebedeva, E. S., & Volchkova, E. V. (2021) · Russian Medical Inquiry · doi:10.32364/2587-6821-2021-5-7-492-496 · Cited by 2
Multiscale network analysis identifies potential receptors for SARS‐CoV ‐2 and reveals their tissue‐specific and age‐dependent expression
Forst, C. V., Zeng, L., Wang, Q., Zhou, X., Vatansever, S., Xu, P., Song, W., Tu, Z., & Zhang, B. (2023) · FEBS Letters · doi:10.1002/1873-3468.14613 · Cited by 4
High-throughput sequencing approaches applied to SARS-CoV-2
Ong’era, E. M., Mohammed, K. S., Makori, T., Bejon, P., Ocholla-Oyier, L. I., Nokes, D. J., Agoti, C. N., & Githinji, G. (2023) · Wellcome Open Research · doi:10.12688/wellcomeopenres.18701.1 · Cited by 2
The cross-talk study between immune system and SARS-CoV-2
Alamer, E. (2023) · Journal Of Advanced Pharmacy Education And Research · doi:10.51847/8u5axm8acl · Cited by 2
Ventilatory support and inflammatory peptides in hospitalised patients with COVID-19: A prospective cohort trial
Gysan, M. R., Milacek, C., Bal, C., Zech, A., Brugger, J., Milos, R., Antoniewicz, L., Idzko, M., & Gompelmann, D. (2023) · PLoS ONE · doi:10.1371/journal.pone.0293532 · Cited by 2
The Effects of Severe Symptoms of SARS-CoV-2 Infections on the Anti/Proapoptotic Molecules: A 6-Month Cohort Study
Karimi‐Googheri, M., Madjd, Z., Kiani, J., Shabani, Z., Arababadi, M. K., & Gholipourmalekabadi, M. (2024) · Viral Immunology · doi:10.1089/vim.2024.0060 · Cited by 2
Development and validation of a nomogram to assess the occurrence of liver dysfunction in patients with COVID-19 pneumonia in the ICU
Wang, Z., Zhao, L., & Xie, K. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-10684-1 · Cited by 2
The Monoclonal Antibody Recognized the Open Reading Frame Protein in Porcine Circovirus Type 2-Infected Peripheral Blood Mononuclear Cells
Hung, L.-C. (2020) · Viruses · doi:10.3390/v12090961 · Cited by 2
A parsimonious approach for recognizing SARS‐CoV‐2 and host interactions
Ganguly, B. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26824 · Cited by 1
Spotlight on Immunity against COVID-19 with Emphasis on Cytokine Storm
Aldahlawi, A., & Zaher, K. A. (2021) · Pharmacophore · doi:10.51847/lyeebiyjer · Cited by 2
Quantitative Insight into Immunopathology of SARS-CoV-2 Infection
Soni, B., Kabra, R., & Singh, S. (2021) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2020.0156 · Cited by 2
Diagnostic Value of Serum Level of Interleukin 33 (IL-33), C-C Motif Chemokine Ligand 17 (CCL17) and Interferon Gamma Inducible Protein-10 (IP-10) in Coronavirus Disease 2019 (COVID-19) Patients
Moustafa, N. M., Mohamed, R. H., Elsaid, R., & Mahmoud, F. (2022) · The Egyptian Journal of Medical Microbiology · doi:10.21608/ejmm.2022.211933 · Cited by 2
Construction of Gene Expression Patterns to Identify Critical Genes Under SARS-CoV-2 Infection Conditions
Xiao, Y., Li, W., Wang, J., Wu, X., & Sheng, B. (2023) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2023.3283534 · Cited by 2
p53 and RNA viruses: The tug of war
Pal, A., Tripathi, S. K., Rani, P., Rastogi, M., & Das, S. (2023) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1826 · Cited by 2
Development of mRNA nano-vaccines for COVID-19 prevention and its biochemical interactions with various disease conditions and age groups
Baig, M. M. F. A., Wong, L. Y., & Wu, H. (2023) · Journal of drug targeting · doi:10.1080/1061186x.2023.2288996 · Cited by 2
Self-citation
Innovative diagnostic approach and investigation trends in COVID19-A systematic review
Gururaj, N., Rachel, J. B., Smitha, T. V., Daniel, T., Harishini, B., & Rosaian, A. (2020) · Journal of Oral and Maxillofacial Pathology · doi:10.4103/jomfp.jomfp_395_20 · Cited by 2
Severe Acute Respiratory Syndrome Coronavirus 2 Dynamics of Human Infection: Molecular Biology, Virology, and Immunology
Mwapagha, L. M., Abugri, J., Kennedy, J., Zivuku, M., & Onywera, H. (2022) · Exploratory Research and Hypothesis in Medicine · doi:10.14218/erhm.2022.00111 · Cited by 2
Transcriptomic profiling of disease severity in patients with COVID-19 reveals role of blood clotting and vasculature related genesPreprint
Masood, K. I., Mahmood, S. F., Shahid, S., Nasir, N., Ghanchi, N. K., Nasir, A., Jamil, B., Khanum, I., Razzak, S. A., Kanji, A., et al. (2020) · medRxiv · doi:10.1101/2020.06.18.20132571 · Cited by 2
Transcriptomic dysregulations associated with SARS-CoV-2 infection in human nasopharyngeal and peripheral blood mononuclear cellsPreprint
de Melo, C. V. B., Bhuiyan, M. A., Gatua, W., Kanyerezi, S., Uzairue, L. I., Abechi, P., Kumar, K., Rahmat, J., Giwa, A. O., Mwandira, G., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.09.289850 · Cited by 2
Evidence of a dysregulated Vitamin D pathway in SARS-CoV-2 infected patient’s lung cellsPreprint
George, B., Amjesh, R., Paul, A. M., Kumar, T. R. S., Pillai, M. R., & Kumar, R. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.21.423733 · Cited by 2
Can corticosteroids improve the outcomes of patients with Covid-19? A retrospective cohort study of patients within and outside the epicentrePreprint
Yu, H., Li, P., Wang, T., Yao, R., Ni, Z., Yang, H., Liang, B., Liu, D., Luo, F., Chen, H., et al. (2020) · doi:10.21203/rs.3.rs-32279/v1 · Cited by 2
Intersection between ageing-related Genes and SARS-CoV-2 Interactome: Is it higher than expected?Preprint
Guzzi, P. H., Pedace, E., & Giorgi, F. M. (2020) · doi:10.21203/rs.3.rs-137634/v1 · Cited by 2
Myxobacterial Depsipeptide Chondramides Interrupt SARS-CoV-2 Entry by Targeting Its Broad, Cell Tropic Spike Protein: Antagonistic Prospects for Anti-COVID-19 Drug DiscoveryPreprint
Fernandez, R. A. T., Quimque, M. T. J., Notarte, K. I., Manzano, J. A., Pilapil, D. Y. H., de Leon, V. N., Jose, J. J. P. S., Villalobos, O. A., & Macabeo, A. P. G. (2021) · ChemRxiv · doi:10.26434/chemrxiv.14043641 · Cited by 2
Non-productive exposure of PBMCs to SARS-CoV-2 induces cell-intrinsic innate immunity responsesPreprint
Kazmierski, J., Friedmann, K., Postmus, D., Fischer, C., Jansen, J., Richter, A. M., de Jarcy, L. B., Schüler, C., Sohn, M., Sauer, S., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.15.480527 · Cited by 2
Tempering Macrophage plasticity for controlling SARS-CoV-2 infection for managing COVID-19 diseasePreprint
Toor, D., Jain, A., Kalhan, S., Manocha, H., Sharma, V. K., Jain, P., Tripathi, V., & Prakash, H. (2020) · doi:10.31219/osf.io/g2vwm · Cited by 2
Discovering hub genes involved in the pathophysiological impact of COVID-19 on diabetes kidney disease by differential gene expression and interactome analysisPreprint
Osuna‐Martínez, U., Aviña‐Padilla, K., Olimón-Andalón, V., Angulo‐Rojo, C., Guadrón‐Llanos, A. M., Rivas-Ferreira, J. C., Urrea, F., & Calderón-Zamora, L. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.11.511826 · Cited by 2
Human ACE-2, MCP1 and micro-RNA 146 as Novel Markers for COVID- 19 Affection and Severity
Abd-Elsalam, S. M., Mohamed, A. A., Abdelghani, A., Hassan, M. B., Ghaith, D. M., Ezzat, O., El-damasy, D. A., Madbouli, N. N., Hamada, M., El‐Kady, M. A., et al. (2022) · Infectious Disorders - Drug Targets · doi:10.2174/1871526522666220829153042 · Cited by 1
COVID-19 induced ARDS: immunopathology and therapeutics
Das, S., Sharma, T., Bhardwaj, A., & Srivastava, R. K. (2023) · Exploration of Immunology · doi:10.37349/ei.2023.00101 · Cited by 1
Analysis of the Glycoprotein Properties and Glycan Structures of Chicken Angiotensin Converting Enzyme 2
Ji, X., Ma, C., Zhang, Y., Du, X., & Zhang, Y. (2023) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-023-10568-5 · Cited by 1
Cytokine profiles of mild-to-moderate SARS-CoV-2 infected and recovered pre-vaccinated individuals residing in Indonesia
Megasari, N. L. A., Khairunisa, S. Q., Arizandy, R. Y., Wijaksana, I. K. E., & Wungu, C. D. K. (2024) · PeerJ · doi:10.7717/peerj.17257 · Cited by 1
ABO gene polymorphism and COVID-19 severity: The impact on haematological complications, inflammatory markers, and lung lesions
Samet, M., Mahdiabadi, P. R., Tajamolian, M., Jelodar, M. G., Monshizadeh, K., Javazm, R. R., Yazdi, M., Abessi, P., & Hoseini, S. M. (2024) · Human Immunology · doi:10.1016/j.humimm.2024.111184 · Cited by 1
Unravelling the transcriptomic characteristics of bronchoalveolar lavage in post-covid pulmonary fibrosis
Ali, M. S., Hadda, V., Verma, S., Chopra, A., Mittal, S., Madan, K., Tiwari, P., Suri, T. M., & Mohan, A. (2025) · BMC Medical Genomics · doi:10.1186/s12920-025-02110-x · Cited by 1
Immune transcriptomic analysis on COVID-19 patients with varying clinical presentations identifies severity markers
Abdallah, A. M., Ansari, H., Shuaib, M., Doudin, A., Yassine, H. M., Shah, S. S. U. D., Mir, F., Emara, M., Elzouki, A.-N., & Cyprian, F. (2025) · Scientific Reports · doi:10.1038/s41598-025-04837-0 · Cited by 1
SARS ‐ CoV ‐2‐Induced Phosphorylation of HSPA9 at Ser627: Potential Implications for Mitochondrial Function, Cell Cycle Regulation, and Immune Evasion
Guo, Z., Xie, C., Lai, X., Zhang, Y., Gao, Y., Wang, R., Zeng, Z., & Zhou, Z. (2025) · The FASEB Journal · doi:10.1096/fj.202501244r · Cited by 1
Directional False Discovery Rate Control in Large‐Scale Multiple Testing Under Data Dependence
Li, W., Shi, J., Wang, Y. V., & Xiang, D. (2025) · Applied Stochastic Models in Business and Industry · doi:10.1002/asmb.70041 · Cited by 1
CASPASE-3 expression and activity in PBMCs associate with SARS-CoV-2 infection and clinical features
de Carvalho, V. M. F., Silva, B. D. O., de Oliveira, P. S. S., da Costa, T. B., da Rosa, M. M., Rêgo, M. J. B. D. M., Pereira, M. C., & Pitta, M. G. D. R. (2025) · Clinical Immunology Communications · doi:10.1016/j.clicom.2025.09.004 · Cited by 1
The neutrophil‐to‐lymphocyte ratio as a marker of immunosenescence and COVID‐19 outcomes in the elderly: A narrative review
Gasmi, M., Torabinasab, K., Williams‐Hooker, R., Marsigliante, S., & Muscella, A. (2026) · Physiological Reports · doi:10.14814/phy2.70682 · Cited by 4
Mixed lineage kinase 3 mediates SARS‐CoV‐2‐induced kidney injury via the Hsp70‐IL‐17A axis
Kumar, S., Singh, S. K., Srivastava, P., Mahendiran, S., Nair, R. S., Vyas, H., Jha, S., Nag, N., Viswakarma, N., Kapoor, H., et al. (2026) · Interdisciplinary medicine · doi:10.1002/inmd.70154 · Cited by 1
Lung Ultrasound (LUS) in COVID-19 Pneumonia: Usefulness in Two Atypical Cases
Giugno, V., Marzio, G. D., Domânico, A., & Accogli, E. (2020) · European Journal of Case Reports in Internal Medicine · doi:10.12890/2020_001800 · Cited by 1
Afecciones renales por COVID-19: Revisión sistemática.
Félix-Mendoza, A. G., Flores-Parada, G. V., González-González, F. J., Picos-Contreras, J. A., & Campa-Navarro, A. B. (2021) · REMUS - Revista Estudiantil de Medicina de la Universidad de Sonora · doi:10.59420/remus.6.2021.5 · Cited by 1
Secondary Infections in Critically Ill Patients with COVID-19
Grasselli, G., Cattaneo, E., & Florio, G. (2021) · Annual update in intensive care and emergency medicine · doi:10.1007/978-3-030-73231-8_5 · Cited by 1
Novel Cellular Stress Models with Implications in Understanding and Treating ENT Pathologies
Panda, N. K., Sharma, M., Ramavat, A. S., Patro, S. K., Nayak, G. R., & Kaushal, K. (2022) · Springer eBooks · doi:10.1007/978-981-16-8845-4_7 · Cited by 1
Human genes with relative synonymous codon usage analogous to that of polyomaviruses are involved in the mechanism of polyomavirus nephropathy
Yu, F., Guo, D., Zhao, S., Wei, Q., Li, Y., & Lin, T. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.992201 · Cited by 1
Self-citation
Effect of methylprednisolone therapy on hospital stay and viral clearance in patients with moderate COVID-19
Li, X., Yuan, X., Xu, Z., Huang, L., Shi, L., Lu, X., Wang, F., & Fu, J. (2022) · Infectious Medicine · doi:10.1016/j.imj.2022.09.004 · Cited by 1

Authors: Xiong, Y., Liu, Y., Cao, L., Wang, D., Guo, M., Jiang, A., Guo, D., Hu, W., Yang, J., Tang, Z., Wu, H., Lin, Y., Zhang, M., Zhang, Q., Shi, M., Liu, Y., Zhou, Y., Lan, K., & Chen, Y.
Affiliations: Wuhan University (CN)
Sun Yat-sen University (CN)
BGI Group (China) (CN)
State Key Laboratory of Virology, Modern Virology Research Center, College of Life Sciences, Wuhan University
The Centre for Infection and Immunity Studies, School of Medicine, Sun Yat-sen University
Corresponding author: Zhou, Yu
Lan, Ke
Chen, Yu
ORCID: Xiong, Yong
Liu, Yuan
Cao, Liu
Wang, Dehe
Guo, Ming
Jiang, Ao
Guo, Dong
Hu, Wenjia
Yang, Jiayi
Wu, Honglong
Lin, Yongquan
Zhang, Qi
Liu, Yingle
Zhou, Yu
Lan, Ke
Chen, Yu
Venue: Emerging Microbes & Infections
Publisher: Informa UK Limited
Published: 2020-01
Volume: 9
Issue: 1
Pages: 761-770
ISSN: 2222-1751 (ISSN-L)
DOI: 10.1080/22221751.2020.1747363
PMC: PMC7170362
OpenAlex: W3013843138
Cited by: 1,076
References: 53
Citations by year: 2026: 12 · 2025: 27 · 2024: 68 · 2023: 121 · 2022: 206 · 2021: 370 · 2020: 272
FWCI: 31.89
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0/ (unspecified)
Locations: Emerging Microbes & Infections (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Informationszentrum Lebenswissenschaften (ZB MED) (submittedVersion, cc-by)
Funders: National Natural Science Foundation of China (31871316, COVID-19)
Wuhan University
National Science and Technology Major Project (#2018ZX10733403)
Topics: Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
Keywords: COVID-19 pandemic, SARS-CoV-2, bronchoalveolar lavage fluid, peripheral blood mononuclear cells, host immune response, inflammatory cytokines, chemokines, lymphopenia, apoptosis, p53 pathway, lymphocyte activation, transcriptome
MeSH terms: Betacoronavirus, RNA-Seq, COVID-19, SARS-CoV-2, Bronchoalveolar Lavage Fluid, Humans, Leukocytes, Mononuclear, Lymphopenia, Pneumonia, Viral, Signal Transduction, Tumor Suppressor Protein p53, Cytokines, Apoptosis, Coronavirus Infections, Chemokines, Pandemics, Transcriptome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients

Abstract

Overview

Integrity signals

Figures

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks